It is considered that activation of nicotinic a 7 receptors (a 7 nAChR) is useful for the treatment of cognitive disturbances in schizophrenia and Alzheimer's disease. Recently, selective a 7 nAChR agonists have been discovered and are used to validate the a 7 nAChR as a drug target for the treatmen
Ganglionic nicotinic acetylcholine receptor activation by the novel agonist ABT-418
β Scribed by Clark A. Briggs; Marion L. Hughes; Lisa M. Monteggia; Tony Giordano; Diana Donnelly-Roberts; Stephen P. Arneric
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 761 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
## Abstract Mice with deletions of nicotinic ACh receptor (nAChR) subunit genes are valuable models for studying nAChR functions. We could previously show in the mouse superior cervical ganglion (SCG) that the absence of distinct subunits affects the functional properties of receptors. Here, we hav
## Abstract Neonicotinoids are synthetic, nicotineβderived insecticides used for agricultural and household pest control. Though highly effective at activating insect nicotinic receptors, many neonicotinoids are also capable of directly activating and/or modulating the activation of vertebrate nico